UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
OrbiMed Israel GP Ltd. 89 MEDINAT HAYEHUDIM ST BUILDING E, 11TH FLOOR HERZLIYA, L3 4614001 |
 X |  X |  |  |
OrbiMed Israel BioFund GP Limited Partnership 89 MEDINAT HAYEHUDIM ST BUILDING E, 11TH FLOOR HERZLIYA, L3 4614001 |
 X |  X |  |  |
/s/ Ryan A. Murr, as attorney-in-fact for OrbiMed Israel GP Ltd. | 05/11/2017 | |
**Signature of Reporting Person | Date | |
/s/ Ryan A. Murr, as attorney-in-fact for OrbiMed Israel BioFund Limited Partnership | 05/11/2017 | |
**Signature of Reporting Person | Date |
No securities are beneficially owned | |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
 Remarks: Exhibit List: Exhibit 24.1 - Power of Attorney for OrbiMed Israel GP Ltd. Exhibit 24.2 - Power of Attorney for OrbiMed BioFund Limited Partnership This report on Form 3 is jointly filed by OrbiMed Israel GP Ltd. and OrbiMed Israel BioFund GP Limited Partnership. The Reporting Persons have designated a representative, currently Erez Chimovits, to serve on the Issuer's board of directors. This report on Form 3 shall not be deemed an admission that any such entity or person, including the Reporting Persons, is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose |